Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Capital Expenditures (2022 - 2025)

Cardio Diagnostics Holdings' Capital Expenditures history spans 4 years, with the latest figure at $162834.0 for Q3 2025.

  • For Q3 2025, Capital Expenditures rose 600.48% year-over-year to $162834.0; the TTM value through Sep 2025 reached $190955.0, down 74.48%, while the annual FY2024 figure was $214765.0, 62.69% down from the prior year.
  • Capital Expenditures for Q3 2025 was $162834.0 at Cardio Diagnostics Holdings, up from $18696.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $537053.0 in Q4 2023 and bottomed at -$256991.0 in Q2 2023.
  • The 4-year median for Capital Expenditures is $21615.5 (2024), against an average of $97201.6.
  • The largest annual shift saw Capital Expenditures plummeted 99.32% in 2024 before it surged 600.48% in 2025.
  • A 4-year view of Capital Expenditures shows it stood at $188674.0 in 2022, then soared by 184.65% to $537053.0 in 2023, then tumbled by 99.32% to $3638.0 in 2024, then soared by 4375.92% to $162834.0 in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Capital Expenditures are $162834.0 (Q3 2025), $18696.0 (Q2 2025), and $5787.0 (Q1 2025).